The lawsuit alleges that Gilead engaged in a variety ... too much for certain drugs used to treat and prevent HIV (Truvada, Atripla, and their generic equivalents). The Settlement resolves the ...

The drugs in question are Viread, Truvada, Atripla, Complera and Stribild ... according to their lawsuit. But Gilead shelved that compound for years so as to not pull sales from its TDF products ...

Later it was combined with other HIV medicines and sold under additional brand names, including Atripla, Truvada, Stribild and Complera. The lawsuits say that Gilead knew when Viread was approved ...

or Atripla from October 26, 2001, through the present, who were personally or whose physician was exposed to Gilead’s misrepresentations.” The lawsuit asserts: “After learning that TAF had a ...

Atripla and Truvada generics eventually graced ... Last month, meanwhile, a California judge ruled that Gilead must contend with a lawsuit alleging anticompetitive conduct tied to the 2014 patent ...

Truvada and Atripla. At the heart of the case is the idea of "reverse-payment agreements," in which a party, usually a generic drug maker, agrees to drop a patent lawsuit against a brand name ...

According to the 2020 lawsuit, Gilead was able to maintain its ... Emtriva and another drug called Atripla. While terms of the eventual 2014 settlement were not disclosed, the trust alleged ...